PHIO PHARMACEUTICALS CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
PHIO PHARMACEUTICALS CORP. (PHIO) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 1.12 thousand shares as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2026-03-05
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 1.12K shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 1.12K shares.
- 2018-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 36.48K shares.
- 2017-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 33.91K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number as first filed |
|---|---|---|
| 2025-12-31 | 1.12K shares 10-K · filed 2026-03-05 | |
| 2025-09-30 | 1.12K shares 10-Q · filed 2025-11-13 | |
| 2018-03-31 | 36.48K shares 10-Q · filed 2018-05-10 | |
| 2017-12-31 | 33.91K shares 10-K · filed 2018-03-26 | |
| 2017-09-30 | 35.49K shares 10-Q/A · filed 2018-03-26 | 354.96K shares 10-Q · filed 2017-11-08 |
| 2017-06-30 | 32.83K shares 10-Q/A · filed 2018-03-26 | 328.32K shares 10-Q · filed 2017-08-10 |
| 2017-03-31 | 30.80K shares 10-Q/A · filed 2018-03-26 | 308.06K shares 10-Q · filed 2017-05-11 |
| 2016-12-31 | 304.88K shares 10-K · filed 2017-03-30 | |
| 2016-09-30 | 298.35K shares 10-Q · filed 2016-11-10 | |
| 2016-06-30 | 288.35K shares 10-Q · filed 2016-08-11 | |
| 2016-03-31 | 263.23K shares 10-Q · filed 2016-05-12 | |
| 2015-12-31 | 2.50M shares 10-K · filed 2016-03-30 | |
| 2015-09-30 | 2.38M shares 10-Q · filed 2015-11-12 | |
| 2015-06-30 | 2.22M shares 10-Q · filed 2015-08-12 | |
| 2015-03-31 | 1.91M shares 10-Q · filed 2015-05-13 | |
| 2014-12-31 | 1.74M shares 10-K · filed 2015-03-30 | |
| 2014-09-30 | 1.58M shares 10-Q · filed 2014-11-13 | |
| 2014-06-30 | 1.43M shares 10-Q · filed 2014-08-14 | |
| 2014-03-31 | 1.16M shares 10-Q · filed 2014-05-14 | |
| 2013-12-31 | 1.02M shares 10-K · filed 2014-03-28 | |
| 2013-09-30 | 873.81K shares 10-Q · filed 2013-11-14 | |
| 2013-06-30 | 727.90K shares 10-Q · filed 2013-08-14 | |
| 2013-03-31 | 9.05M shares 10-Q · filed 2013-05-15 | |
| 2012-12-31 | 4.72M shares 10-K · filed 2013-03-29 | |
| 2012-09-30 | 1.90M shares 10-Q · filed 2012-11-13 | |
| 2012-06-30 | 348.81K shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |